200,000+ products from a single source!
sales@angenechem.com
Home > Indoles and Oxindole > 187947-37-1
CAS No: 187947-37-1 Catalog No: AG002GLA MDL No:MFCD02179189
Title | Journal |
---|---|
Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1. | The Journal of biological chemistry 20140411 |
N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze. | Behavioural brain research 20120801 |
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. | Molecular pain 20110101 |
The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. | Pharmacological research 20100601 |
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. | Pharmacological research 20100401 |
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands. | Bioorganic & medicinal chemistry letters 20091201 |
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems. | Neurobiology of disease 20091001 |
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090201 |
The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats. | Neuropharmacology 20081201 |
Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors. | American journal of physiology. Regulatory, integrative and comparative physiology 20081101 |
Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation. | Developmental neurobiology 20081001 |
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system. | Developmental neurobiology 20080915 |
New N-arachidonoylserotonin analogues with potential 'dual' mechanism of action against pain. | Journal of medicinal chemistry 20071227 |
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. | Journal of molecular medicine (Berlin, Germany) 20071201 |
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. | British journal of pharmacology 20070801 |
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. | British journal of pharmacology 20070301 |
Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. | Biological psychiatry 20060315 |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. | Neuropharmacology 20060301 |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060301 |
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. | Neuropharmacology 20050901 |
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. | Journal of medicinal chemistry 20050811 |
Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. | Biochemical pharmacology 20050801 |
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20041001 |
Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin. | Journal of enzyme inhibition and medicinal chemistry 20030601 |
© 2019 Angene International Limited. All rights Reserved.